Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Biogen
Biogen
Eisai, Biogen's Leqembi nabs UK nod, but reimbursement remains elusive
Fierce Pharma
Thu, 08/22/24 - 11:45 am
Eisai
Biogen
Leqembi
UK
Alzheimer's disease
Biogen sued for alleged PBM kickbacks scheme to boost Tecfidera in wake of generics
Fierce Pharma
Wed, 08/21/24 - 11:41 am
Biogen
Tecfidera
legal
kickbacks
PBMs
generics
Driven by Leqembi, Biogen beats Q2 expectations, raises full-year outlook
Medical Marketing and Media
Thu, 08/1/24 - 11:21 pm
Biogen
earnings
Leqembi
After EU setback, Eisai/Biogen build case for Leqembi
Pharmaphorum
Wed, 07/31/24 - 10:25 am
Eisai
Biogen
Alzheimer's disease
Leqembi
Europe
Eisai 'extremely disappointed' by EMA's decision on Alzheimer's drug
Biopharma Reporter
Tue, 07/30/24 - 11:37 am
Eisai
EMA
Europe
Leqembi
Biogen
Alzheimer's disease
Sage’s recent trial failure adds pressure to its two-drug Biogen collab
Pharma Voice
Mon, 07/29/24 - 10:29 am
SAGE Therapeutics
Biogen
clinical trials
SAGE-324
essential tremor
Zurzuvae
postpartum depression
Eisai and Biogen's Alzheimer's med Leqembi turned down in Europe
Fierce Pharma
Fri, 07/26/24 - 11:15 am
Eisai
Biogen
Leqembi
Europe
Biogen, Sage Scrap Essential Tremor Study After Phase II Failure
BioSpace
Wed, 07/24/24 - 11:55 am
Biogen
SAGE Therapeutics
clinical trials
essential tremors
BIIB124
SAGE-324
Ionis plots next steps for Angelman drug Biogen passed on
BioPharma Dive
Tue, 07/23/24 - 11:15 am
Ionis Pharmaceuticals
Biogen
Angelman Syndrome
ION582
Leqembi sales inch higher; Spark’s pivot leads to layoffs
BioPharma Dive
Fri, 07/12/24 - 11:29 am
Eisai
Biogen
Leqembi
Alzheimer's disease
Roche
Spark Therapeutics
gene therapy
layoffs
Eisai and Biogen launch Alzheimer's drug Leqembi in China
Reuters
Fri, 06/28/24 - 11:18 am
Eisai
Biogen
Alzheimer's disease
Leqembi
China
Don’t call it a comeback: Biotech’s CNS resurgence forges Big Pharma connections
Pharma Voice
Fri, 06/28/24 - 11:17 am
Big Pharma
Neuroscience
Prothena Biosciences
Biogen
Eisai
Pfizer
AbbVie
Eli Lilly
Bristol Myers Squibb
What Would a Donanemab Approval Mean for Leqembi?
BioSpace
Mon, 06/24/24 - 10:47 am
Eli Lilly
donanemab
Biogen
Eisai
Leqembi
FDA
Alzheimer's disease
Biogen’s HI-Bio Buy Is Latest Biopharma Spending Spree in Projected $257B Immunology Market
BioSpace
Wed, 06/12/24 - 11:09 am
Biogen
Hi-Bio
M&A
FDA accepts Eisai's subcutaneous Leqembi filing, sets January 25 decision date
Fierce Pharma
Mon, 06/10/24 - 11:19 am
Eisai
Biogen
Leqembi
FDA
Alzheimer's disease
Biogen, Delta soar together to improve air travel accessibility
Medical Marketing and Media
Thu, 06/6/24 - 09:09 pm
Biogen
philanthropy
SMA
mobility
Novartis, Roche unit and others face Italy antitrust probe over eye drug
Reuters
Thu, 06/6/24 - 11:34 am
Novartis
Roche
Genentech
Italy
antitrust
Biogen
Samsung Bioepis
Byooviz
Companies to watch for potential M&As in 2024
BioSpace
Wed, 06/5/24 - 11:31 am
M&A
Vertex Pharmaceuticals
Regeneron
Biogen
Moderna Therapeutics
European Commission grants marketing approval to Biogen's ALS drug
Reuters
Thu, 05/30/24 - 11:05 pm
Biogen
Europe
Ionis Pharmaceuticals
ALS
Qalsody
Biogen to buy Human Immunology Biosciences in deal worth up to $1.8B
Medical Marketing and Media
Wed, 05/22/24 - 11:38 am
Biogen
Human Immunology Biosciences
M&A
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »